Literature DB >> 2862436

Anti-tumour therapy by induction of endogenous tumour necrosis factor.

M Kato, R Kakehi, G I Soma, T Gatanaga, D Mizuno.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2862436     DOI: 10.1016/s0140-6736(85)90312-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  The antitumour activity of the interferon inducer bropirimine is partially mediated by endogenous tumour necrosis factor alpha.

Authors:  M Scheringa; J N IJzermans; J Jeekel; R L Marquet
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

2.  The endogenous induction of tumor necrosis factor serum (TNS) for the adjuvant postoperative immunotherapy of cancer--changes in immunological markers of the blood.

Authors:  Y Abe; M Miyake; T Miyazaki; A Horiuchi; S Kimura
Journal:  Jpn J Surg       Date:  1990-01

3.  Induction of tumor growth inhibitory factor (TGIF) in human mononuclear cells by OK-432, a streptococcal preparation.

Authors:  M Katano; H Yamamoto; T Mizoguchi; T Hisatsugu
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

4.  Induction of an endogenous tumor necrosis factor in mice by murine recombinant interferon-gamma combined with a lipid A subunit analog (GLA-60) of low toxicity.

Authors:  I Saiki; H Maeda; T Sakurai; J Murata; J Iida; M Kiso; A Hasegawa; I Azuma
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

5.  The elevation of plasma soluble tumor necrosis factor receptor levels by TNF induction therapy for patients with malignancy.

Authors:  Y Abe; K Kimura; A Horiuchi; Y Watanabe; S Kimura
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

6.  Intratumoral induction of tumour necrosis factor by systemic administration of Bordetella pertussis vaccine.

Authors:  H Minagawa; H Kobayashi; H Yoshida; M Teranishi; A Morikawa; S Abe; H Oshima; D I Mizuno
Journal:  Br J Cancer       Date:  1990-09       Impact factor: 7.640

Review 7.  Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease?

Authors:  Enrique Z Fisman; Alexander Tenenbaum
Journal:  Cardiovasc Diabetol       Date:  2014-06-23       Impact factor: 9.951

8.  Endogenous tumor necrosis factor induction with Bordetella pertussis vaccine as a triggering agent and its therapeutic effect on MM46 carcinoma-bearing mice.

Authors:  H Minagawa; Y Kakamu; H Yoshida; F Tomita; H Oshima; D Mizuno
Journal:  Jpn J Cancer Res       Date:  1988-03

9.  A possible role of glucocorticoids: an intrinsic inhibitor of the cytotoxic activity of tumor necrosis factor.

Authors:  S Abe; T Yamamoto; S Iihara; M Yamazaki; D Mizuno
Journal:  Jpn J Cancer Res       Date:  1988-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.